Statistics for A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease

Total visits

views
A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease 234

Total visits per month

views
April 2024 0
May 2024 0
June 2024 0
July 2024 0
August 2024 0
September 2024 0
October 2024 0

File Visits

views
Weir_2017_US.pdf 481

Top country views

views
United States 177
Germany 7
Ukraine 7
China 4
United Kingdom 4
Russia 3
Thailand 3
Canada 2
India 2
Switzerland 1
Czechia 1
Italy 1
South Korea 1
Malaysia 1
Singapore 1

Top city views

views
Wilmington 52
Fairfield 23
Houston 14
Ann Arbor 11
Jacksonville 7
Kiev 7
Cambridge 6
Kiez 6
Beijing 3
San Francisco 3
Washington 3
Arkadelphia 2
Baltimore 2
Bangkok 2
Mumbai 2
Saint Petersburg 2
Seattle 2
Toronto 2
Basel 1
Bloomington 1
Brooklyn 1
Columbia 1
Fort Washington 1
Gunzenhausen 1
Irvine 1
Lake Mary 1
Monmouth Junction 1
Moscow 1
Overland Park 1
Philadelphia 1
Rome 1
Scottsdale 1
Seremban 1
Shenzhen 1
Uherske Hradiste 1
White Plains 1
Woburn 1
Yongin-si 1